Choy Wen Jie, Phan Kevin, Diwan Ashish D, Ong Chon Sum, Mobbs Ralph J
Faculty of Medicine, University of New South Wales (UNSW), Sydney, Australia.
NeuroSpine Surgery Research Group (NSURG), Prince of Wales Private Hospital, Sydney, Australia.
BMC Musculoskelet Disord. 2018 Aug 16;19(1):290. doi: 10.1186/s12891-018-2213-5.
Lumbar intervertebral disc herniation is a common cause of lower back and leg pain, with surgical intervention (e.g. discectomy to remove the herniated disc) recommended after an appropriate period of conservative management, however the existing or increased breach of the annulus fibrosus persists with the potential of reherniation. Several prosthesis and techniques to reduce re-herniation have been proposed including implantation of an annular closure device (ACD) - Barricaid™ and an annular tissue repair system (AR) - Anulex-Xclose™. The aim of this meta-analysis is to assist surgeons determine a potential approach to reduce incidences of recurrent lumbar disc herniation and assess the current devices regarding their outcomes and complications.
Four electronic full-text databases were systematically searched through September 2017. Data including outcomes of annular closure device/annular repair were extracted. All results were pooled utilising meta-analysis with weighted mean difference and odds ratio as summary statistics.
Four studies met inclusion criteria. Three studies reported the use of Barricaid (ACD) while one study reported the use of Anulex (AR). A total of 24 symptomatic reherniation were reported among 811 discectomies with ACD/AR as compared to 51 out of 645 in the control group (OR: 0.34; 95% CI: 0.20,0.56; I = 0%; P < 0.0001). Durotomies were lower among the ACD/AR patients with only 3 reported cases compared to 7 in the control group (OR: 0.54; 95% CI: 0.13, 2.23; I = 11%; P = 0.39). Similar outcomes for post-operative Oswestry Disability Index and visual analogue scale were obtained when both groups were compared.
Early results showed the use of Barricaid and Anulex devices are beneficial for short term outcomes demonstrating reduction in symptomatic disc reherniation with low post-operative complication rates. Long-term studies are required to further investigate the efficacy of such devices.
腰椎间盘突出症是下背部和腿部疼痛的常见原因,在经过适当的保守治疗后,建议进行手术干预(如椎间盘切除术以切除突出的椎间盘),然而,纤维环现有的或增加的破裂仍然存在,有再次突出的可能性。已经提出了几种减少再次突出的假体和技术,包括植入环形闭合装置(ACD)——Barricaid™和环形组织修复系统(AR)——Anulex-Xclose™。本荟萃分析的目的是帮助外科医生确定一种潜在的方法来降低复发性腰椎间盘突出症的发生率,并评估当前这些装置的疗效和并发症。
通过系统检索四个电子全文数据库至2017年9月。提取包括环形闭合装置/环形修复结果的数据。所有结果采用荟萃分析进行汇总,以加权平均差和比值比作为汇总统计量。
四项研究符合纳入标准。三项研究报告使用Barricaid(ACD),一项研究报告使用Anulex(AR)。在811例使用ACD/AR进行椎间盘切除术的患者中,共报告了24例有症状的再次突出,而在对照组的645例中有51例(比值比:0.34;95%置信区间:0.20,0.56;I² = 0%;P < 0.0001)。ACD/AR组的硬脊膜切开术较少,仅报告了3例,而对照组为7例(比值比:0.54;95%置信区间:0.13,2.23;I² = 11%;P = 0.39)。比较两组时,术后奥斯威斯残疾指数和视觉模拟量表的结果相似。
早期结果表明,使用Barricaid和Anulex装置对短期结果有益,显示出有症状的椎间盘再次突出减少,术后并发症发生率低。需要进行长期研究以进一步调查这些装置的疗效。